for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chongqing Zhifei Biological Prdct Co Ltd

300122.SZ

Latest Trade

160.00CNY

Change

1.60(+1.01%)

Volume

11,150,879

Today's Range

154.58

 - 

160.60

52 Week Range

42.90

 - 

194.21

As of on the Shenzhen Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
158.40
Open
158.38
Volume
11,150,879
3M AVG Volume
433.44
Today's High
160.60
Today's Low
154.58
52 Week High
194.21
52 Week Low
42.90
Shares Out (MIL)
1,600.00
Market Cap (MIL)
253,440.00
Forward P/E
--
Dividend (Yield %)
0.32

Latest Developments

更多

Chongqing Zhifei Biological Products' Q3 Net Profit Up 58.1% Y/Y

Shenzhen Exchange Filing Shows Block Trade Of Zhifei Biological Products' Shares Involving 507.4 Mln Yuan

Shenzhen Exchange Filing Shows Block Trade Of Chongqing Zhifei Biological Products' Shares Involving 455 Mln Yuan

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Chongqing Zhifei Biological Prdct Co Ltd

Chongqing Zhifei Biological Products Co., Ltd. is a China-based company principally engaged in the research, development, production, sale and distribution of vaccine products. The Company's main products include bacterial vaccines for the prevention of meningitis and pneumonia-based bacteria, biological products for the prevision and treatment of tuberculosis, viral vaccines for the prevention of rabies virus, influenza virus and other virus, general drugs and other biological products, among others. The Company is also involved in the agency sale of vaccines. The Company distributes its products in domestic market and to overseas markets, with Central China as its main market.

Industry

Biotechnology & Drugs

Contact Info

25F

No. 7, Jinyuan Road, Jiangbei District

CHONGQING, CHO

400020

China

+86.23.86358226

http://www.zhifeishengwu.com

Executive Leadership

Rensheng Jiang

Chairman of the Board, General Manager

Lingfeng Jiang

Vice Chairman of the Board, Deputy General Manager

Zhenjing Li

Chief Financial Officer, Deputy General Manager, Director

Xisheng Jiang

Deputy General Manager

Haiitan Sun

Deputy General Manager

Key Stats

1.46 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2017

1.3K

2018

5.2K

2019

10.6K

2020(E)

14.9K
EPS (CNY)

2017

0.270

2018

0.907

2019

1.479

2020(E)

2.090
Price To Earnings (TTM)
82.23
Price To Sales (TTM)
18.14
Price To Book (MRQ)
34.13
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
48.57
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
48.14
Return on Equity (TTM)
23.00

Latest News

Latest News

FACTBOX- The race for a coronavirus vaccine

(Adds IDT Biologika; updates AstraZeneca, Russia vaccine, Johnson & Johnson) Oct 14 (Reuters) - More than 150 potential vaccines are being developed and tested globally to stop the COVID-19 pandemic, with 42 in human trials, according to the World Health Organization (WHO...

FACTBOX-The race for a coronavirus vaccine

More than 150 potential vaccines are being developed and tested globally to stop the COVID-19 pandemic, with 38 in human trials, according to the World Health Organization (WHO). The following list tracks the latest developments from major drugmakers and research institutes...

《股市简讯》A股医药类股大幅下挫,投资者忧虑估值过高

0221GMT - * 中国医药股股价大幅下跌,沪深医药卫生指数一度下滑3.3%--有可能连续第三天收低 * 尽管周一下跌,但该指数今年以来仍上涨逾50%,涨幅名列前茅,因投资者在新冠疫情期间追捧医药股 * 国信证券分析师在报告中称,由于估值过高,医药股面临修正风险 * 复星医药领跌,一度下跌7%,上周五下挫8%;其在香港上市的股票也跌3.1% * 沃森生物、智飞生物、华兰生物、康泰生物和康弘药业 下跌5.5-7%不等 (完) (编译 郑茵 审校 艾茂林)

FACTBOX-The race for a coronavirus vaccine

(Updates Johnson & Johnson; adds Cadila Healthcare Ltd, University of Queensland) July 17 (Reuters) - More than 100 vaccines are being developed and tested around the world to stop the COVID-19 pandemic, which has killed hundreds of thousands and ravaged the global economy...

New Chinese billionaires outpace U.S. by 3 to 1 - Hurun

China minted three times as many new billionaires than the United States in the past year, with fortunes made in drugs and online entertainment after a mini-boom from the coronavirus outbreak, a ranking of the world's wealthiest people shows.

《中国报摘》--其他报纸重要消息8月14日

--保利地产半年度报告显示,报告期内,公司实现归属于上市公司股东的净利润65.05亿元人民币,同比增长15.13%。中国证券金融股份有限公司持股由一季度末的5.14亿股增加至5.81亿股,持股比例由4.33%上升至4.9%。

沪综指早盘升逾1% 国常会释放政策放松信号基建股等领涨

中国股市沪综指周二早盘上涨逾1%。分析师指出,周一国务院常务会议透露政策放松信号,刺激市场人气继续回暖,基建等政策受益板块涨幅居前,大盘继续上涨。

沪综指放量收升逾1%至一个月新高 受央行意外“放水”提振

中国股市沪综指周一放量收升逾1%,至一个月新高。分析师指出,周末出台的资管新规配套细节有助于提升市场风险偏好,今早央行意外进行巨量中期借贷便利(MLF)操作,资金面宽松预期再起,银行股及钢铁基建等周期股走势明显强劲,推动大盘震荡向上。

多只生物疫苗股早盘跌停 长生生物事件引发全行业被彻查

长生生物<002680.SZ>疫苗事件继续发酵,国务院总理李克强要求对所有疫苗生产、销售等全流程全链条进行彻查,国内股市生物疫苗相关股票周一早盘初大跌,多只个股跌停。

《中国报摘》--其他报纸重要消息5月4日

--地方一季度GDP数据日前基本出炉。在已公布数据的30个省份中,有18个省份一季度经济增速跑赢全国同期6.8%的水平。记者梳理发现,地方未来政策重点瞄准扩大内需和对外开放两个方面。其中,在扩大内需方面,投资仍被置于重要位置。

《中国报摘》--其他报纸重要消息5月3日

--智飞生物与默沙东签署补充协议,将独家代理其九价HPV疫苗(宫颈癌疫苗)。西南证券预测,参考香港的预约价格,内地9价HPV疫苗中标价应该在1,000元人民币以上,预计九价疫苗市场空间将达135亿元。

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up